Redundant function of retinoic acid receptor isoforms in leukemogenesis unravels a prominent function of genome topology and architecture in the selection of mutagenic events in cancer

Leukemia

Volumn 23, Issue 2, 2009, Pages 417-419

  Marinelli, A ^a   Bossi, D ^b   Pelicci, P G ^a,b   Minucci, S ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR GAMMA;

CANCER GENETICS; CELL SELECTION; CHROMOSOME 15; CHROMOSOME 17; CHROMOSOME TRANSLOCATION; DISEASE MODEL; FLUORESCENCE ACTIVATED CELL SORTING; GENOME; HEMATOPOIETIC STEM CELL; IMMUNOPHENOTYPING; LETTER; LEUKEMOGENESIS; MUTAGENESIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RECEPTOR INTRINSIC ACTIVITY;

EID: 60149085217     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2008.205     Document Type: Letter

References (8)

1. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 1996; 10: 940-954.
2. Purton LE, Dworkin S, Olsen GH, Walkley CR, Fabb SA, Collins SJ et al. RARγ is critical for maintaining a balance between haematopoietic stem cell self-renewal and differentiation. J Environ Monit 2006; 203: 1283-1293.
3. Lin RJ, Egan DA, Evans RM. Molecular genetics of acute promyelocytic leukaemia. Trends Genet 1999; 15: 179-184.
4. Melnick A, Licht JD. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 1999; 93: 3167-3215.
5. Marinelli A, Bossi D, Pelicci PG, Minacci S. A redundant oncogenic potential of the retinoic receptor (RAR) alpha, beta and gamma isoforms in acute promyelocytic leukaemia. Leukaemia 2007; 21: 647-6450.
6. Minucci S, Monestiroli S, Giavara S, Ronzoni S, Marchesi F, Insinga A et al. PML-RAR induces promyelocytic leukemias with high efficiency following retroviral gene transfer into purified murine haematopoietic progenitors. Blood 2002; 100: 2989-2995.
7. Westervelt P, Lane AA, Pollock JL, Oldfather K, Holt MS, Zimonjic DB et al. High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARalpha expression. Blood 2003; 102: 1857-1865.
8. Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Donti E et al. Acute promyelocytic leukemia: From genetics to treatment. Blood 1994; 83: 10-25.